• HOME
    KOREAN
    CHINESS
    SITE MAP
    JOIN
  • Username (Site Login ID)
  • Password
  • Forgot your password?

  • ½É¸®Àûµµ¹Ú | Cases and Studies in Pathological Gambling | êý戏设计

    date : 2015-05-20 01:10|hit : 2626
    Article] Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists
    DocNo of ILP: 4408

    Doc. Type: Article

    Title: Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists

    Authors: Tippmann-Peikert, M; Park, JG; Boeve, BF; Shepard, JW; Silber, MH

    Full Name of Authors: Tippmann-Peikert, M.; Park, J. G.; Boeve, B. F.; Shepard, J. W.; Silber, M. H.

    Keywords by Author:

    Keywords Plus: PARKINSONS-DISEASE; THERAPY; DRUGS

    Abstract: Pathologic gambling is an impulse control disorder previously reported to complicate dopamine agonist therapy in patients with Parkinson disease. It has not been described in association with dopamine agonist therapy of other conditions. We report three patients treated in our sleep disorders center who developed pathologic gambling while receiving treatment with dopamine agonists for restless legs syndrome.

    Cate of OECD: Clinical medicine

    Year of Publication: 2007

    Business Area: gamble

    Detail Business: gamble

    Country: USA

    Study Area:

    Name of Journal: NEUROLOGY

    Language: English

    Country of Authors: Mayo Clin, Sleep Disorders Ctr, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; Mayo Clin, Coll Med, Div Pulm & Crit Care Med, Rochester, MN USA

    Press Adress: Tippmann-Peikert, M (reprint author), Mayo Clin, Sleep Disorders Ctr, Eisenberg Bldg 8G,200 1st St SW, Rochester, MN 55905 USA.

    Email Address: tippmannpeikert.maja@mayo.edu

    Citaion:

    Funding:

    Lists of Citation: Avanzi M, 2004, NEUROL SCI, V25, P98, DOI 10.1007/s10072-004-0238-z; Bergh C, 1997, PSYCHOL MED, V27, P473, DOI 10.1017/S0033291796003789; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422; Gschwandtner U, 2001, CLIN NEUROPHARMACOL, V24, P170, DOI 10.1097/00002826-200105000-00009; HUTSON PH, 1984, J NEUROCHEM, V43, P291, DOI 10.1111/j.1471-4159.1984.tb06713.x; Molina JA, 2000, MOVEMENT DISORD, V15, P869, DOI 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I; Perachon S, 1999, EUR J PHARMACOL, V366, P293, DOI 10.1016/S0014-2999(98)00896-6; Piercey MF, 1998, CLIN NEUROPHARMACOL, V21, P141; Shaffer HJ, 2001, CAN J PUBLIC HEALTH, V92, P168

    Number of Citaion: 10

    Publication: LIPPINCOTT WILLIAMS & WILKINS

    City of Publication: PHILADELPHIA

    Address of Publication: 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA

    ISSN: 0028-3878

    29-Character Source Abbreviation: NEUROLOGY

    ISO Source Abbreviation: Neurology

    Volume: 68

    Version: 4

    Start of File: 301

    End of File: 303

    DOI: 10.1212/01.wnl.0000252368.25106.b6

    Number of Pages: 3

    Web of Science Category: Clinical Neurology

    Subject Category: Neurosciences & Neurology

    Document Delivery Number: 128EA

    Unique Article Identifier: WOS:000243639800015

    [ÀÌ °Ô½Ã¹°Àº HyeJung Mo¡¦´Ô¿¡ ÀÇÇØ 2015-05-20 20:14:55 GAMBLING¿¡¼­ À̵¿ µÊ]
    reply : 0
  • list
  • prev
  • next